Researchers explored the combination of anti-PD-1 and an adenovirus engineered to carry tumor necrosis factor-alpha (TNF-α) and IL-2 (Ad5-CMV-mTNFα/mIL-2) in a mouse NSCLC model (131). Here, IL2 is linked to non-small cell lung carcinoma.